A study of 84 breastfeeding women in Israel, published in the Journal of the American Medical Association, showed that after receiving two doses of the Pfizer/BioNTech COVID-19 vaccine, they had “robust" amounts of antibodies in samples of their breast milk for 6 weeks post-vaccination. Researchers said four of the babies registered a fever in the first 3 weeks of the study, and all of the infants showed symptoms of upper respiratory tract infections.
Full Story: Healio (free registration) (4/19)